BA
ALT icon

BlackRock Advisors’s Altimmune ALT Stock Holding History

BlackRock Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$121K Buy
124
+2
+2% +$1.79K ﹤0.01% 2952
2016
Q3 		$106K Buy
122
+14
+13% +$11K ﹤0.01% 2988
2016
Q2 		$79K Buy
108
+60
+125% +$41K ﹤0.01% 3069
2016
Q1 		$27K Hold
48
– – ﹤0.01% 3359
2015
Q4 		$28K Hold
48
– – ﹤0.01% 3387
2015
Q3 		$19K Hold
48
– – ﹤0.01% 3520
2015
Q2 		$26K Buy
48
+21
+78% +$10.6K ﹤0.01% 3439
2015
Q1 		$13K Hold
27
– – ﹤0.01% 3508
2014
Q4 		$14K Buy
+27
New +$13.9K ﹤0.01% 3571

Other funds holding ALT

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock Advisors's ALT Position: Q4 2016 in Review

BlackRock Advisors increased its Altimmune (ALT) stake by 1.6% in Q4 2016, buying an estimated $1.79K and bringing the position to 124 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #2952.

BlackRock Advisors first reported a position in ALT in Q4 2014 and has held it in 9 quarters since. 88 funds tracked by Wall St. Rank hold ALT as of Q4 2016.

  • BlackRock Advisors held 124 shares of Altimmune worth $121K as of Q4 2016.
  • BlackRock Advisors bought 2 Altimmune shares in Q4 2016, an estimated $1.79K.
  • Altimmune made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2952 holding.
  • BlackRock Advisors first reported a position in Altimmune in Q4 2014 and has held it in 9 quarters since.
  • 88 funds tracked by Wall St. Rank held Altimmune as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.